Hsp90

Hsp90

For Philadelphia chromosome-positive ALL sufferers, it is strongly recommended to change the therapeutic method of tyrosine-kinase-inhibitor-based treatment in conjunction with steroids instead of multi-agent chemotherapy [58,59]

For Philadelphia chromosome-positive ALL sufferers, it is strongly recommended to change the therapeutic method of tyrosine-kinase-inhibitor-based treatment in conjunction with steroids instead of multi-agent chemotherapy

View More